Skip to main content
Caplight Logo









Solarea Bio

Solarea Bio

Private
Waltham, MassachusettsHealthcare & Life Scienceshttps://solaria.bio/

Last Round

Grant

Aug 23, 2023

Total Funding Raised

$14.4M

Company Overview

Solarea Bio is a biotechnology company that develops microbiome-based medical foods and therapeutics designed to address age-related inflammatory conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, D2C Brands, Drug Discovery

Business Model

B2C

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

medical foodsynbioticgut-bone axisbone healthmicrobiome therapeuticsAI-driven drug discoverybiotechpersonalized nutritiongut healthD2C healthosteopeniarheumatoid arthritisbiohackingdigital healthlongevity

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Solarea Bio Comparables

Compare Solarea Bio with similar companies based on industry and business-model similarity.

Solarea Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pendulum Therapeutics
65%
Symrise AG
64%
BioGaia AB (publ)
62%

Solarea Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 23, 2023
Series BMay 8, 2023
Series AOct 19, 2020
AcceleratorJul 26, 2017

Solarea Bio Investors

Notable investors and investment history

Solarea Bio investors
InvestorRounds
Viking Global InvestorsSeries A, Series B
National Institute on AgingGrant
BOLD Capital PartnersSeries B, Series A
S2G InvestmentsSeries A, Series B
Illumina AcceleratorAccelerator

Solarea Bio Filings

Explore SEC and related filing metadata, where available.

Solarea Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Solarea Bio's valuation, stock price, and market status.

Is Solarea Bio a public or private company?

Solarea Bio is a private company.

What is the current stock price of Solarea Bio?

Solarea Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Solarea Bio worth (valuation)?

Valuation information for Solarea Bio is not publicly available.

Can I buy Solarea Bio stock?

Solarea Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Solarea Bio's last funding round?

Solarea Bio's most recent funding round was Grant on August 23, 2023.

Who are the main investors in Solarea Bio?

Key investors in Solarea Bio include BOLD Capital Partners, S2G Investments.

Will Solarea Bio IPO soon?

No public IPO plans have been announced for Solarea Bio.

How can I track Solarea Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Solarea Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWaltham, Massachusetts
Employee Range17
Year Founded2017
Last FundingAug 23, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?